Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

41.20 +1.06 (+2.64%)
Official Closing Price Updated: 7:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,968,714
Open 41.61
Bid (Size) 40.25 (1)
Ask (Size) 41.50 (5)
Prev. Close 40.14
Today's Range 40.95 - 41.61
52wk Range 37.96 - 47.49
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Where Boston Scientific Stands With Analysts
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market... 
Via Benzinga

Performance

YTD
-4.45%
-4.45%
1 Month
-4.32%
-4.32%
3 Month
-8.65%
-8.65%
6 Month
+6.82%
+6.82%
1 Year
-1.81%
-1.81%

More News

Read More
This Foreboding Sign Looms Over Boston Scientific's Chart
Via Benzinga
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook
Via Benzinga
5 Analysts Have This to Say About Boston Scientific
Via Benzinga
Boston Scientific Jumps On Upbeat Q2, FY22 Guidance
Via Benzinga
Why Is Boston Scientific Stock Trading Lower Premarket Today?
Via Benzinga
Boston Scientific Ekes Out A Narrow First-Quarter Beat, Offers So-So Sales Guide
Via Investor's Business Daily
Recap: Boston Scientific Q1 Earnings
Via Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Via Benzinga
Goldman Sachs And 3 Other Stocks Insiders Are Selling
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Via Investor's Business Daily
CNBC's Final Trades: Amazon, FedEx And These Health Care Picks
Via Benzinga
All The Stocks That Moved Friday From CNBC's 'Fast Money: Halftime Report'
Via Benzinga
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
Via Investor's Business Daily
Hopeful Golden Cross Forms On Boston Scientific's Chart
Via Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
Via Investor's Business Daily
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Executives Sell More Than $210M Of 5 Stocks
Via Benzinga
What 5 Analyst Ratings Have To Say About Boston Scientific
Via Benzinga
Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat
Via Investor's Business Daily
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Via Benzinga
Boston Scientific: Q4 Earnings Insights
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.